Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

SZSE:300357 Lagerbericht

Marktkapitalisierung: CN¥12.3b

Zhejiang Wolwo Bio-Pharmaceutical Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 5/6

Zhejiang Wolwo Bio-Pharmaceutical has been growing earnings at an average annual rate of 2.5%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 8.8% per year. Zhejiang Wolwo Bio-Pharmaceutical's return on equity is 12.1%, and it has net margins of 34.5%.

Wichtige Informationen

2.5%

Wachstumsrate der Gewinne

2.5%

EPS-Wachstumsrate

Pharmaceuticals Wachstum der Industrie10.9%
Wachstumsrate der Einnahmen8.8%
Eigenkapitalrendite12.1%
Netto-Marge34.5%
Letzte Ertragsaktualisierung30 Sep 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.'s (SZSE:300357) P/E Is Still On The Mark Following 39% Share Price Bounce

Sep 30
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.'s (SZSE:300357) P/E Is Still On The Mark Following 39% Share Price Bounce

These 4 Measures Indicate That Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Is Using Debt Reasonably Well

Sep 26
These 4 Measures Indicate That Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Is Using Debt Reasonably Well

Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Has Announced That Its Dividend Will Be Reduced To CN¥0.185

Jun 30
Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Has Announced That Its Dividend Will Be Reduced To CN¥0.185

Investor Optimism Abounds Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357) But Growth Is Lacking

May 27
Investor Optimism Abounds Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357) But Growth Is Lacking

Calculating The Fair Value Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357)

May 07
Calculating The Fair Value Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357)

Is Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) A Risky Investment?

Mar 22
Is Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) A Risky Investment?

Aufschlüsselung der Einnahmen und Ausgaben

Wie Zhejiang Wolwo Bio-Pharmaceutical Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

SZSE:300357 Einnahmen, Ausgaben und Erträge (CNY Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Sep 24905312427122
30 Jun 24891311410122
31 Mar 24881317401118
31 Dec 23848310384112
30 Sep 23870292380108
30 Jun 23893316379107
31 Mar 23882328365104
01 Jan 23896349361106
30 Sep 22888391357103
30 Jun 22849372339100
31 Mar 2284135934195
31 Dec 2180833833688
30 Sep 2176532432078
30 Jun 2172431930375
31 Mar 2169130828370
31 Dec 2063627826361
30 Sep 2063028125756
30 Jun 2062427525748
31 Mar 2061227425742
31 Dec 1963929825937
30 Sep 1961529025629
30 Jun 1955625923519
31 Mar 1953224722216
31 Dec 1850123320512
30 Sep 1847822718810
30 Jun 1843921117111
31 Mar 184112001639
31 Dec 173861861586
30 Sep 173671751565
30 Jun 173441541570
31 Mar 173241391530
31 Dec 163121291510
30 Sep 163031291410
30 Jun 162831211360
31 Mar 162771221300
31 Dec 152671181260
30 Sep 152611161210
30 Jun 152521121180
31 Mar 152471101160
31 Dec 142401001220
30 Sep 14228901210
30 Jun 14211781160
31 Mar 14202681140
31 Dec 13194711020

Qualität der Erträge: 300357 has high quality earnings.

Wachsende Gewinnspanne: 300357's current net profit margins (34.5%) are higher than last year (33.5%).


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 300357's earnings have grown by 2.5% per year over the past 5 years.

Beschleunigtes Wachstum: 300357's earnings growth over the past year (7.1%) exceeds its 5-year average (2.5% per year).

Erträge im Vergleich zur Industrie: 300357 earnings growth over the past year (7.1%) exceeded the Pharmaceuticals industry -1.2%.


Eigenkapitalrendite

Hohe Eigenkapitalrendite: 300357's Return on Equity (12.1%) is considered low.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren